InvestLog
RLAY Relay Therapeutics, Inc. logo

RLAY Relay Therapeutics, Inc.

Healthcare
$14.17+4.73%ClosedMarket Cap: $2.71B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

1

Dispositions

7

Buy/Sell Ratio

0.14

Net Shares

-40,449

Shares Acquired

1,800

Shares Disposed

42,249

Total Bought ($)

$0.00

Total Sold ($)

$6.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 14Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$12.86195,178
Thu Apr 30Rahmer Peterofficer: See remarksSell753$14.79275,857
Thu Apr 30Catinazzo Thomasofficer: Chief Financial OfficerSell972$14.79212,895
Thu Apr 30Bergstrom Donald Aofficer: President, R&DSell1,490$14.79418,557
Thu Apr 09Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$13.01213,867
Thu Apr 09Catinazzo Thomasofficer: Chief Financial OfficerSell1,800$15.00213,867
Thu Apr 09Catinazzo Thomasofficer: Chief Financial OfficerSell1,800$5.22215,667
Wed Mar 11Catinazzo Thomasofficer: Chief Financial OfficerSell17,717$10.06231,584
Thu Jan 29Rahmer Peterofficer: See remarksSell11,684$7.62277,964
Thu Jan 29Rahmer Peterofficer: See remarksSell1,354$8.45276,610
Thu Jan 29Rahmer Peterofficer: See remarksSell994$2.99338,463
Thu Jan 29Catinazzo Thomasofficer: Chief Financial OfficerSell13,820$7.62250,996
Thu Jan 29Catinazzo Thomasofficer: Chief Financial OfficerSell1,695$8.45249,301
Thu Jan 29Bergstrom Donald Aofficer: President, R&DSell18,895$7.62422,733
Thu Jan 29Bergstrom Donald Aofficer: President, R&DSell2,686$8.45420,047